PDCD1 and intrahepatic cholangiocarcinoma: conducted an evaluation on the effectiveness of combining Lenvatinib with a PD-1 inhibitor in a cohort of 40 patients diagnosed with intrahepatic cholangiocarcinoma (ICC), who had experienced treatment failure with chemotherapy for advanced disease.